Oruka Therapeutics General Counsel Paul T. Quinlan sells $706,734.83 in common shares

Oruka Therapeutics General Counsel Paul T. Quinlan sold 9,000 common shares on October 20, 2026, and exercised warrants for 9,000 shares at $7.80 each. He directly held 29,995 common shares and 70,996 employee warrants after the transactions.